What people are saying - Write a review
We haven't found any reviews in the usual places.
Global Industry Perspective
8 other sections not shown
acquisition Amgen antibodies aptamers Asia-Pacific Asian avian flu big pharma biofuels Biogen Idec biologics biotech companies biotech industry biotech sector biotechnology biotechnology companies biotechnology industry boost Canada Canadian cancer challenges China Chinese clinical trials commercialization compa companies by segment competitive costs deals diagnostic diseases drug development drug discovery early-stage emerging equity Ernst & Young Europe European biotech financing firms focus focused funding gene Genentech genetic Genomics Germany GlaxoSmithKline Global Biotechnology growth increased India industry's initial public offerings innovative investment investors IPOs Japan's late-stage launched M&As manufacturing market capitalization medicine ment mergers million molecular nology Novartis panies partners patent percent performance Pharmaceuticals Phase pipeline potential product approvals programs proteins public companies Qiagen recent regulatory revenues rounds SFDA significant Source startup stem cell strategic alliances strong success Switzerland targeted tech therapeutics therapies tion trends ucts vaccines VentureOne